Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Alcon AG (ALC) Ord CHF0.04

Sell:53.92 CHF Buy:53.94 CHF Change: 0.18 CHF (0.33%)
Market closed |  Prices as at close on 18 September 2020 | Switch to live prices |
Sell:53.92 CHF
Buy:53.94 CHF
Change: 0.18 CHF (0.33%)
Market closed |  Prices as at close on 18 September 2020 | Switch to live prices |
Sell:53.92 CHF
Buy:53.94 CHF
Change: 0.18 CHF (0.33%)
Market closed |  Prices as at close on 18 September 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Alcon AG is a Switzerland-based company specialized in the medical industry. The Company operates mainly as an eye care device company. Alcon AG reports its activities into two segments: Surgical and Vision Care. The surgical segment provides a line of ophthalmic surgical products that enable surgeons to achieve accurate results. Its surgical portfolio includes technologies and devices for cataract, retinal, refractive surgery, as well as advanced technology intraocular lenses (ATIOLs) to treat cataracts and refractive errors, such as presbyopia and astigmatism. The surgical segment also includes advanced viscoelastics, surgical solutions, surgical packs and other disposable products for cataract and vitreoretinal surgery. The Vision Care segment manufactures contact lenses and lens care products, such as products for dry eye, contact lens care, ocular allergies, as well as ocular vitamins and redness relievers. The Company also offers continuing education for eye care professionals.

Contact details

Chemin de Blandonnet 8
+ ()

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
26.40 billion CHF
Shares in issue:
489.10 million
Health Care Supplies
SIX Swiss Exchange
Swiss Franc
Swiss All Share Index

Key personnel

  • F. Michael Ball
    Chairman of the Board
  • David Endicott
    Chief Executive Officer, Director
  • D. Keith Grossman
    Vice Chairman of the Board, Senior Independent Director
  • Timothy Stonesifer
    Chief Financial Officer
  • Ian Bell
    President - International
  • Sergio Duplan
    President - North America
  • Michael Onuscheck
    President - Global Businesses and Innovation
  • Rajkumar Narayanan
    Senior Vice President - Operational Strategy, Chief Transformation Officer
  • S Attias
    Head Corporate Development, Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.